Smith & Nephew PLC (SNN)

Smith & Nephew PLC (SNN-N) has garnered positive reviews from analysts, highlighting a significant turnaround achieved under new management in the past four years. The company specializes in orthopedic services, joint repairs, and dressings, and has improved its revenue and profitability, gaining considerable brand recognition. Notably, SNN-N is trading at approximately half the valuation of its major competitor, Stryker, despite showing comparable profitability margins. The consensus among analysts indicates an optimistic outlook, with price targets around $35.82 and expectations of continued growth driven by industry trends. This stock continues to show upside potential operationally, making it an attractive option for long-term investors.